# Varenicline and Bupropion for Smoking Cessation

> **NCT00935818** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 506 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Varenicline
- **DRUG:** placebo
- **DRUG:** bupropion SR

## Key facts

- **NCT ID:** NCT00935818
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 506 (ACTUAL)
- **Last updated:** 2014-05-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935818, "Varenicline and Bupropion for Smoking Cessation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00935818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*